Precigen Inc. (PGEN) is primed for evolution with the beta value of 2.26

Precigen Inc. (PGEN) is priced at $7.17 after the most recent trading session. At the very opening of the session, the stock price was $9.20 and reached a high price of $9.33, prior to closing the session it reached the value of $9.23. The stock touched a low price of $7.00.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on December 16, 2020, Precigen Provides Latest Clinical Developments at Virtual R&D Update Event. – 50% of advanced ovarian cancer patients treated with PRGN-3005 UltraCAR-T® at Dose Level 1 or Dose Level 2 in IP arm experienced regression of target tumor burden -. You can read further details here

5 Stocks to make up the PERFECT 2021 gold portfolio

Gold bugs are shouting from the rooftops in excitement, but that doesn’t mean you rush out and just buy any gold stock…That’s why we laid out The 2021 Ultimate Gold Portfolio – to dissect the treasure from the trash.

Click here to download your free report right away


Precigen Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $9.50 on 12/14/20, with the lowest value was $1.26 for the same time period, recorded on 03/17/20.

Precigen Inc. (PGEN) full year performance was 14.90%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Precigen Inc. shares are logging -24.53% during the 52-week period from high price, and 469.05% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.26 and $9.50.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 3080886 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Precigen Inc. (PGEN) recorded performance in the market was 30.84%, having the revenues showcasing 38.42% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 1.33B, as it employees total of 770 workers.

The Analysts eye on Precigen Inc. (PGEN)

During the last month, 0 analysts gave the Precigen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 5.35, with a change in the price was noted +2.91. In a similar fashion, Precigen Inc. posted a movement of +68.11% for the period of last 100 days, recording 1,166,214 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for PGEN is recording 3.31 at the time of this writing. In addition, long term Debt to Equity ratio is set at 3.31.

Technical rundown of Precigen Inc. (PGEN)

Raw Stochastic average of Precigen Inc. in the period of last 50 days is set at 58.02%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 36.51%. In the last 20 days, the company’s Stochastic %K was 67.93% and its Stochastic %D was recorded 74.83%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Considering, the past performance of Precigen Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 30.84%. Additionally, trading for the stock in the period of the last six months notably improved by 77.48%, alongside a boost of 14.90% for the period of the last 12 months. The shares increased approximately by -14.64% in the 7-day charts and went down by 21.42% in the period of the last 30 days. Common stock shares were driven by 38.42% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free


Please enter your comment!
Please enter your name here